17. Januar 2020
ARCHIMEDlife is very proud to announce the strategic alliance with amedes Holding GmbH, a leading provider in interdisciplinary and...Read more
25. September 2019
Combining high-quality biochemical testing with innovative genetic testing forms a powerful tool for personalized medicine, clinical research and diagnostics...Read more
27. August 2019
Exciting! Our booth with a brand new look and novel, innovative portfolio of diagnostic tests and services. First time...Read more
6. Juni 2019
We are happy to inform you that we have introduced a new diagnostic assay for the analysis of lysosomal...Read more
26. Februar 2019
Quantitative Bestimmung von Psychopharmaka in Blut, Serum oder Plasma Modernste Analysetechnik mittels Klinischer Massenspektrometrie (exakt, sensitiv, schnell) Kompetente fachärztliche Auskunft...Read more
1. Oktober 2018
Results of a prospective study using High-Resolution Mass Spectrometry. The goal of our study, in cooperation with the University...Read more
7. März 2018
The parallel measurement of lyso-GL-3 (lyso-Gb3) for Fabry disease is of high importance particularly for potential female Fabry patients,...Read more
21. November 2017
The 21st of November 2017 is ARCHIMEDlife´s 5th anniversary, a proof that out of an idea you can evolve...Read more
12. November 2017
You can easily subscribe to our bi-monthly ARCHIMEDlife Newsletter and read about laboratory diagnostics, research studies, scientific publications and...Read more
6. November 2017
We took part in the 12th Asia-Pacific Conference on Human Genetics “Genomic Medicine and Clinical Practice” from 8th to...Read more
Started in 2013, ARCHIMEDlife is an independent highly-innovative company dedicated in providing and developing diagnostic services from Inborn Errors of Metabolism to Oncological Diseases. Our commitment is to provide better and faster high-quality laboratory tests for you and your family.
Our diagnostic laboratory is offering services from Clinical Mass Spectrometry to Next-Generation Sequencing. We have international collaborations with physicians, clinical researchers and industry specialized in personalized health care.
We are dedicated to the development of novel laboratory tests to make actionable health information accessible at the time it matters.